Shareholders’ Deficit |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Equity [Abstract] | |
| Shareholders’ Deficit | Note 7 — Shareholders’ Deficit
Preferred Shares — The Company is authorized to issue 1,000,000 preferred shares with a par value of $0.0001 per share. As of June 30, 2026 and December 31, 2025, there were no preferred shares issued or outstanding.
Ordinary Shares — The Company is authorized to issue 200,000,000 ordinary shares with a par value of $0.0001 per share. As of June 30, 2026 and December 31, 2025, there were 2,134,200 ordinary shares issued and outstanding, excluding 411,232 and 417,436 ordinary shares subject to possible redemption, respectively, that are classified as temporary equity.
Warrants — Each Warrant entitles the holder to purchase one Ordinary Share at a price of $11.50 per share, subject to adjustment. The Warrants are exercisable commencing on the later of 30 days after the completion of the initial Business Combination and 12 months from the closing of the IPO, and expire five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. The Company accounts for the Warrants and the Rights as equity-classified instruments based on an assessment of their specific terms and the applicable authoritative guidance in ASC 480 and ASC 815.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|